![](/img/cover-not-exists.png)
Study 2: evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the National Institutes of Health IG02 trial
Stanley C. Jordan, Dolly Tyan, Don M. Stablein, Matthew McIntosh, Ashley VoVolume:
17
Year:
2003
Language:
english
DOI:
10.1016/j.trre.2003.10.003
File:
PDF, 35 KB
english, 2003